Entera Bio Ltd Share Price Today: Live Updates & Key Insights

Entera Bio Ltd share price today is $2.05, up -3.76%. The stock opened at $2.1 against the previous close of $2.13, with an intraday high of $2.1 and low of $2.01.

Entera Bio Ltd Share Price Chart

Entera Bio Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Entera Bio Ltd Share Price Performance

$2.05 -0.0376(-3.76%) ENTX at 27 Jul 2026 02:52 PM Biotechnology
Lowest Today 2.01
Highest Today 2.1
Today’s Open 2.1
Prev. Close 2.13
52 Week High 3.22
52 Week Low 0.91
Day’s Range: Low 2.01 High 2.1
52-Week Range: Low 0.91 High 3.22
1 day return -
1 Week return +6.12
1 month return +27.6
3 month return +80.86
6 month return +35.94
1 year return -0.95
3 year return +177.33
5 year return -59.92
10 year return -

Entera Bio Ltd Institutional Holdings

Knoll Capital Management LP 11.93

Renaissance Technologies Corp 0.96

Parkman Healthcare Partners LLC 0.59

Citadel Advisors Llc 0.50

Seven Fleet Capital Management LP 0.42

Marshall Wace Asset Management Ltd 0.40

Northern Trust Corp 0.30

XTX Topco Ltd 0.27

Schonfeld Strategic Advisors LLC 0.11

Signature Estate & Investment Advisors 0.10

HighTower Advisors, LLC 0.07

Jane Street Group LLC 0.07

Fidelity Nasdaq Composite Index 0.06

Diadema Partners LP 0.05

Geode Capital Management, LLC 0.04

Gem Investment Advisors, LLC 0.04

HRT FINANCIAL LLC 0.03

Point72 Asset Management, L.P. 0.03

Bank of America Corp 0.02

PNC Financial Services Group Inc 0.02

JPMorgan Chase & Co 0.01

Entera Bio Ltd Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Entera Bio Ltd Fundamentals

Market Cap 100.06 M

PB Ratio 9.3627

PE Ratio 0.0

Enterprise Value 96.37 M

Total Assets 15.99 M

Volume 163475

Entera Bio Ltd Company Financials

Annual Revenue FY23:14000 0.0M, FY22:134000 0.1M, FY21:571000 0.6M, FY20:365000 0.4M, FY19:236000 0.2M

Annual Profit FY23:6000 0.0M, FY22:33000 0.0M, FY21:198000 0.2M, FY20:156000 0.2M, FY19:26000 0.0M

Annual Net worth FY23:-9929000 -9.9M, FY22:-13071000 -13.1M, FY21:-12187000 -12.2M, FY20:-9983000 -10.0M, FY19:-10879000 -10.9M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:42000 0.0M, Q3/2024:42000 0.0M

Quarterly Profit Q1/2026:-7000 -0.0M, Q3/2025:-8000 -0.0M, Q2/2025:-7000 -0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Net worth Q1/2026:-3505000 -3.5M, Q3/2025:-3200000 -3.2M, Q2/2025:-2656000 -2.7M, Q1/2025:-2567000 -2.6M, Q3/2024:-3021000 -3.0M

About Entera Bio Ltd & investment objective

Company Information Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures. The company is also involved in the development of EB612, a tablet peptide replacement therapy, which is in Phase I clinical trial for the treatment of hypoparathyroidism; EB618, a GLP-1/glucagon dual agonist peptide, which is in Phase I clinical trial for the treatment of obesity, metabolic, and fibrotic disorders; and GLP-2 which is in Phase I clinical trial for the treatment of short bowel syndrome and disorders related to mucosal inflammation and nutrient malabsorption. It has a collaboration agreement with OPKO Biologics, Inc for the preclinical and clinical development of LA-PTH and oral dual agonist GLP-1/glucagon peptide. The company was incorporated in 2009 and is based in Jerusalem, Israel.

Organisation Biotechnology

Employees 20

Industry Biotechnology

CEO Ms. Miranda J. Toledano M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Entera Bio Ltd FAQs

What is the share price of Entera Bio Ltd today?

The current share price of Entera Bio Ltd is $2.05.

Can I buy Entera Bio Ltd shares in India?

Yes, Indian investors can buy Entera Bio Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Entera Bio Ltd shares in India?

You can easily invest in Entera Bio Ltd shares from India by:

Can I buy fractional shares of Entera Bio Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Entera Bio Ltd?

Entera Bio Ltd has a market cap of $100.06 M.

In which sector does Entera Bio Ltd belong?

Entera Bio Ltd operates in the Biotechnology sector.

What documents are required to invest in Entera Bio Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Entera Bio Ltd?

The PE ratio of Entera Bio Ltd is N/A and the PB ratio is 9.36.